FendX's Nanotechnology to be Presented at the Infection Prevention and Control Canada National Conference
FendX Technologies announced that its nanotechnology product, REPELWRAP™ film, will be featured at the Infection Prevention and Control Canada (IPAC) conference on June 11, 2024. The company's post-doctoral fellow, Dr. Sara Moetakef Imani, will present on the film's capabilities in repelling drug-resistant bacteria and viruses, emphasizing its scalability and potential for enhancing safety in high-touch environments. The IPAC Canada conference provides a platform for highlighting advancements in infection control and public health safety. The film is currently in pilot manufacturing at Dunmore International Corp. for intermediate size real-world testing.
- REPELWRAP™ film's ability to repel drug-resistant bacteria and viruses could significantly enhance public health safety.
- Scalability of REPELWRAP™ film could lead to widespread adoption in high-touch environments.
- Presentation at the IPAC Canada conference provides valuable exposure and credibility within the infection control community.
- Current pilot manufacturing runs indicate progress towards real-world application and commercialization.
- Collaboration with Dunmore International Corp. for pilot manufacturing suggests strong potential for successful scaling.
- No financial data or revenue projections provided, leaving uncertainty about the economic impact.
- Lack of specific timelines for commercial availability could delay investor returns.
- No mention of regulatory approvals, which could be a significant hurdle.
Oakville, Ontario--(Newsfile Corp. - June 6, 2024) - FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D) (the "Company" or "FendX"), a nanotechnology company developing surface protection coatings, announces that advances with REPELWRAP™ film will be featured at the Infection Prevention and Control ("IPAC") Canada conference in St. John's, Newfoundland.
On June 11, 2024, Dr. Sara Moetakef Imani, post-doctoral fellow at McMaster University working on FendX's film nanotechnology projects, will present "A Flexible Film That Repels Drug-Resistant Bacteria and Viruses". Her talk will focus on the film's significant reduction of bacterial and viral contamination, its scalability, and its potential to enhance safety in high-touch environments.
IPAC Canada is a diverse organization dedicated to promoting public health and safety through the advocacy of best practices in infection prevention and control across all settings. The annual conference provides attendees with the chance to explore cutting-edge developments in infection disease control, with the aim of enhancing healthcare safety standards nationwide.
"IPAC Canada 2024 is a great venue to feature our film and its role in keeping surfaces clean and safe. Sara is an integral member of our R&D team who has been instrumental in the numerous advancements we have made with the film, including successfully getting us to the stage of conducting pilot manufacturing runs at Dunmore International Corp. to create intermediate size films for real-world testing," said Dr. Carolyn Myers, President and CEO of FendX.
About FendX Technologies Inc.
FendX is a Canada-based nanotechnology company focused on developing products to make people's lives safer by reducing the spread of pathogens. The Company is developing both film and spray products to protect surfaces from contamination. The lead product under development, REPELWRAP™ film, is a protective surface coating film that, due to its repelling properties, prevents the adhesion of pathogens and reduces their transmission on surfaces prone to contamination. The spray nanotechnology is a bifunctional spray coating being developed to reduce contamination on surfaces by repelling and killing pathogens. The Company is conducting research and development activities using its nanotechnology in collaboration with industry-leading partners, including McMaster University. The Company has exclusive worldwide licenses to its technology and IP portfolio from McMaster, which encompass both film and spray coating nanotechnology formulations.
Contacts:
Dr. Carolyn Myers, CEO and Director
1-800-344-9868
Alyssa Barry, Investor Relations
1-833-947-5227
investor@fendxtech.com
For more information, please visit https://fendxtech.com/ and the Company's profile on SEDAR+ at www.sedarplus.ca.
Neither the Canadian Securities Exchange nor the Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.
Forward-Looking Statements
This news release contains certain forward-looking statements within the meaning of Canadian securities legislation, including with respect to: the plans of the Company; products under development; the advancement of the Company's nanotechnology by researchers at McMaster University; statements regarding the film's potential to enhance safety in high-touch environments; statements regarding creating intermediate size films for real-world testing; and any pathogen reduction benefits related thereto. Although the Company believes that such statements are reasonable, it can give no assurance that such expectations will prove correct. Forward-looking statements are statements that are not historical facts; they are generally, but not always, identified by the words "expects," "plans," "anticipates," "believes," "intends," "estimates," "projects," "aims," "potential," "goal," "objective," "prospective," and similar expressions, or that events or conditions "will," "would," "may," "can," "could" or "should" occur, or are those statements, which, by their nature, refer to future events. The Company cautions that forward-looking statements are based on the beliefs, estimates and opinions of the Company's management on the date the statements are made, and they involve a number of risks and uncertainties. Consequently, there can be no assurances that such statements will prove to be accurate and that actual results and future events could differ materially from those anticipated in such statements.
Important factors that could cause future results to differ materially from those anticipated in these forward-looking statements include: product candidates only being in formulation/reformulation stages; limited operating history; research and development activities; dependence on collaborative partners, licensors and others; effect of general economic and political conditions; and other risk factors set forth in the Company's public filings which are available on SEDAR+ at www.sedarplus.ca. The reader is urged to refer to such public filings for a more complete discussion of such risk factors and their potential effects. Except to the extent required by applicable securities laws and the policies of the Canadian Securities Exchange, the Company undertakes no obligation to update these forward-looking statements if management's beliefs, estimates or opinions, or other factors, should change.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/211829
FAQ
What is the REPELWRAP™ film developed by FendX Technologies?
When and where will the REPELWRAP™ film be presented?
Who will present the REPELWRAP™ film at the IPAC conference?
What are the key features of the REPELWRAP™ film?
What stage is the REPELWRAP™ film currently in?
Which company is collaborating with FendX Technologies for pilot manufacturing?
What is the stock symbol for FendX Technologies?
